insights_auto
Miks on EVT langenud? 3,57%?
Uurige põhjalikumaltchevron_right
EVT:ETR
Evotec SE
2,92 €
arrow_downward
−3,57%(−0,11) 1 p
2. okt, 17:35:12 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse EVT põhistatistika genereerimine…
Ava
3,05 €
Kõrge
3,05 €
Madal
2,90 €
Turu kapit.
511,78 mln
Keskm. maht
909,90 tuh
Maht
662,38 tuh
52 näd kõrgeim
7,30 €
52 näd madalaim
2,71 €
Aktsiatulu
−1,11 €
Käibivad aktsiad
177,91 mln
Töötajate arv
4 tuh
Ava
3,05 €
Kõrge
3,05 €
Madal
2,90 €
Turu kapit.
511,78 mln
Keskm. maht
909,90 tuh
Maht
662,38 tuh
52 näd kõrgeim
7,30 €
52 näd madalaim
2,71 €
Aktsiatulu
−1,11 €
Käibivad aktsiad
177,91 mln
Töötajate arv
4 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
1 päeva eest
Evotec announces science chief change. Evotec stock trades at EUR 2.93 versus EUR 2.93.
AD HOC NEWS
·
1 päeva eest
Evotec stock after-hours at EUR 2.92: minus 4.26 percent
AD HOC NEWS
·
2 päeva eest
Evotec announces science chief exit and Evotec stock falls 3.93 percent
AD HOC NEWS
·
3 päeva eest
Evotec stock pre-market at EUR 3.13: plus 0.32 percent
Profiil
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Teave üksuse Evotec SE kohta